| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 04/01/2009 | CN101397566A Superoxide dismutase and coding gene thereof |
| 04/01/2009 | CN101397553A Glucose isomerase mutant |
| 04/01/2009 | CN101397552A High efficiency recombinant expressed chitoanase |
| 04/01/2009 | CN101397551A Neukinase and its use in treatment of cardiovascular disease |
| 04/01/2009 | CN101397550A Mutant firefly luciferase |
| 04/01/2009 | CN101397549A Aryl hydrocarbon hydroxylase system and use |
| 04/01/2009 | CN101397543A Methylosinus trichosporium and use thereof |
| 04/01/2009 | CN100473662C Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 03/31/2009 | US7511191 Raffinose synthase genes and their use |
| 03/31/2009 | US7511189 Using vector transformation to generate seed with enhanced size/weight, carbon influx, fatty acid synthesis and oil content |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511128 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 03/31/2009 | US7511027 Administering a nucleoside or a nucleoside analog, such as (5'-fluoro-5-methyl-beta-arabinofuranosyl-uridine) or salt or prodrug that suppresses the expression of hepatitis B surface or preS1 antigen in the host 100-fold |
| 03/31/2009 | US7511024 Factor VII or VIIA-like molecules |
| 03/31/2009 | US7511018 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 03/31/2009 | US7511005 Lipolytic enzyme elip |
| 03/31/2009 | US7510869 A pSYCO109mcs plasmid comprising restriction endonuclease recognition sites useful for cloning at least three different genes or operons, each flanked by a terminator sequence and variants of glucose isomerase promoters for varying levels of protein expression |
| 03/31/2009 | US7510861 Gluconate dehydratase |
| 03/31/2009 | US7510860 Xylanases with enhanced thermophilicity and alkalophilicity |
| 03/31/2009 | US7510859 Shampoo, hair dye, hair bleach, denture care, anticaries agents, detergents, rinses, antiseptics; low temperature bleach boosters; controlled release bleach at milder pH |
| 03/31/2009 | US7510858 IRAK 1c splice variant and its use |
| 03/31/2009 | US7510857 Thermostable cellulase and methods of use |
| 03/31/2009 | US7510854 Using transgenic gramnegative bacteria as biorecator for fermentation of methione and lysine for use in medicine, cosmetics and animal feeds |
| 03/31/2009 | US7510851 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
| 03/31/2009 | US7510831 Expression vector comprising nucleotide sequences coding phytase for use in transformation and expression in aspergillus; enhancing nutrient quality of animal feeds |
| 03/31/2009 | US7510717 Non-toxic mutants of pathogenic gram-negative bacteria |
| 03/31/2009 | CA2192467C Calcium binding recombinant antibody against protein c |
| 03/26/2009 | WO2009039487A1 Chimeric cytochrome p450 proteins and methods of use |
| 03/26/2009 | WO2009038729A2 Compositions and methods utilizing fibrin beta chain fragments of the bbeta chain of fibrinogen |
| 03/26/2009 | WO2009038195A1 Mutant pyrrolysyl-trna synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same |
| 03/26/2009 | WO2009037861A1 Β-glucuronidase inhibitor |
| 03/26/2009 | WO2009037510A1 Dna decatenation assay 997 |
| 03/26/2009 | WO2009037502A1 Modified xylan production |
| 03/26/2009 | WO2009037258A1 Improved-performance proteases and detergents and cleaning agents comprising said proteases |
| 03/26/2009 | WO2009037253A2 Polypeptides having tyrosinase activity and polynucleotides encoding same |
| 03/26/2009 | WO2009037252A1 Method for producing an acidified milk drink |
| 03/26/2009 | WO2009037217A1 Method for producing 2-methyl-1,2-dihydroxypropane |
| 03/26/2009 | WO2009037216A1 Method for the oxidation of methyl groups in aliphatic hydrocarbons using an enzyme system with the activity of a monooxygenase |
| 03/26/2009 | WO2009036997A1 Truncated secretory aspartyl proteinase 2 |
| 03/26/2009 | WO2009021034A3 Methods of treating b-cell cancers |
| 03/26/2009 | WO2009011795A3 Methods for treating stress induced emotional disorders |
| 03/26/2009 | WO2008135467A3 Enhancement of seed oil / amino acid content by combinations of pyruvate kinase subunits |
| 03/26/2009 | WO2008097366A3 Metabolically engineered escherichia coli for enchanced production of sialic acid |
| 03/26/2009 | WO2008008070A3 Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose |
| 03/26/2009 | WO2005077046A3 A composition and method of treating mastitis |
| 03/26/2009 | WO2005030924A3 Genetic markers for skatole metabolism |
| 03/26/2009 | WO2005002521A3 Methods for the identification of inhibitors of acetolactate synthase and potassium transport protein as antibiotics |
| 03/26/2009 | WO2004097028A3 Discovery of biocatalysts and biocatalytic activities using nuclear magnetic resonance and deuterium |
| 03/26/2009 | US20090083886 Transgenic plants with increased glycine-betaine |
| 03/26/2009 | US20090082600 Native homoethanol Pathway for ethanol production in E. coli |
| 03/26/2009 | US20090082537 Four branched dendrimer-peg for conjugation to proteins and peptides |
| 03/26/2009 | US20090082456 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082435 Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders |
| 03/26/2009 | US20090082350 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082329 Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors |
| 03/26/2009 | US20090082296 Mycobacterial antigens expressed during latency |
| 03/26/2009 | US20090082273 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 03/26/2009 | US20090082267 Prevention and Reduction of Blood Loss |
| 03/26/2009 | US20090082264 123 Human Secreted Proteins |
| 03/26/2009 | US20090082262 Processed human chemokines PHC-1 and PHC-2 |
| 03/26/2009 | US20090082246 Amylase Variants |
| 03/26/2009 | US20090081788 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| 03/26/2009 | US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 03/26/2009 | US20090081778 Nucleic acid encoding a fusion protein incorporating a cysteinized ribonuclease |
| 03/26/2009 | US20090081777 Nucleic acid encoding cysteinized ribonuclease to which a targeting moiety can be conjugated |
| 03/26/2009 | US20090081776 Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an n-terminal leader sequence that is at least one residue long |
| 03/26/2009 | US20090081763 Novel protein-deamidating enzyme, microorganism producing the same, gene encoding the same, production process therefor, and use thereof |
| 03/26/2009 | US20090081762 Superactive Cellulase Formulation Using Cellobiohydrolase-1 from Penicillium Funiculosum |
| 03/26/2009 | US20090081761 Modified hydrogenase, enzymatic electrode made of modified hydrogenase, and hydrogenase modification method |
| 03/26/2009 | US20090081760 Dmo methods and compositions |
| 03/26/2009 | US20090081759 Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of the amino acid sequence of a known ribonuclease and an n-terminal leader sequence that is at least one residue long |
| 03/26/2009 | US20090081758 Chimeric Cytochrome P450 Proteins and Methods of Use |
| 03/26/2009 | US20090081757 Adsorbents Comprising Anthraquinone Dye-Ligends for the Separation of Biological Materials |
| 03/26/2009 | US20090081756 Nucleic acid-enzyme complex |
| 03/26/2009 | US20090081754 Gene of enzyme having activity to generate lachrymatory factor |
| 03/26/2009 | US20090081753 Method for formulating and immobilizing a matrix protein and a matrix protein for use in a sensor |
| 03/26/2009 | US20090081736 Methods For Using Mutant RNA Polymerases Wtih Reduced Discrimination Between Non-Canonical Nucleoside Triphosphates |
| 03/26/2009 | US20090081734 Arabinitol Dehydrogenases from Neurospora crassa |
| 03/26/2009 | US20090081731 Method of producing catalytically active BACE2 enzymes |
| 03/26/2009 | US20090081730 Activatable recombinant neurotoxins |
| 03/26/2009 | US20090081715 Engineered Light-Emitting Reporter Genes |
| 03/26/2009 | US20090081706 Crystalline form of the catalytic domain of aurora 2 kinase and methods of use thereof |
| 03/26/2009 | US20090081704 Compositions, methods and kits for real-time enzyme assays using charged molecules |
| 03/26/2009 | US20090081687 Nucleic Acid Molecules and Other Molecules Associated with Plants |
| 03/26/2009 | US20090081680 Mutant firefly luciferase |
| 03/26/2009 | US20090081672 Testing by immunoassay for overexpression which is an indicator of breast cancer; relates to cDNA sequences from a region of amplification on chromosome 20 associated with disease. used in hybridization methods for the identification of chromosomal abnormalities |
| 03/26/2009 | US20090081668 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 03/26/2009 | US20090081635 Modified heparinase iii and methods of sequencing therewith |
| 03/26/2009 | US20090081354 Phytate Polynucleotides and Methods of Use |
| 03/26/2009 | US20090081331 Phytase |
| 03/26/2009 | US20090081280 Compositions and methods for modulating hemostasis |
| 03/26/2009 | US20090081257 Hydrogenase deficient bacterial strains |
| 03/26/2009 | US20090081218 Fusion proteins |
| 03/26/2009 | US20090081207 High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity |
| 03/26/2009 | US20090081200 Tissue Factor Antibodies and Uses Thereof |
| 03/26/2009 | US20090081189 Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells |
| 03/26/2009 | US20090081188 Complex of factorix and polyoxyethylene glycol; stimulant blood coagulation; blood disorders |
| 03/26/2009 | US20090081185 Apoptotic agents |
| 03/26/2009 | US20090081182 Modified Lecithin-Cholesterol Acyltransferase Enzymes |
| 03/26/2009 | US20090081180 Antimicrobial polymer conjugates |